Search Result for 'Oral peptide delivery'

have improved the treatment of chronic diseases including autoimmune, metabolic disorders, and cancer. However, their administration via injections can prove a ...

convenient, patient-friendly, and easiest mode of drug delivery (Table 1), it is most of the time characterized by low peptide ...

route . Furthermore, transcellular transport is not expected to be the main contributor to improve delivery of hydrophilic drugs such ...

infection, and chronic pain. Since the first medical use of insulin almost a century ago, many peptide drugs have been ...

Abstract Inherent susceptibility of peptides to enzymatic degradation in the gastrointestinal tract is a key bottleneck in oral peptide drug ...

Yet, their clinical application is generally restricted to injectable therapies. The main challenge hindering their broader use through globally accessible, ...

free drug, with the mechanisms shifting to energy-dependent pathways (adsorptive/clathrin-mediated) instead of passive diffusion/MRP5 efflux. The formulation, enhanced further by ...

but encouraging progress towards 1) adapting conventional drug development and delivery approaches to infants and 2) designing novel infant-centric formulations. ...

marketed oral peptide drug products with systemic targets for patients. To overcome these biological barriers, both pharmaceutical companies and academic ...

Abstract Purpose of review Herein, we present an overview of innovative oral technologies utilized in colonic drug delivery systems that ...